Nebulized versus intravenous tranexamic acid for coughing up blood
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests two ways to give a medicine called tranexamic acid (which helps blood clot) to people who are coughing up blood. One way is through a nebulizer (breathing in a mist), and the other is through an IV (into a vein). The goal is to see which method works better to stop the bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had mild to moderate coughing up of blood (less than about 100 mL, or half a cup, in a day) in the last 24–48 hours, or are still bleeding.
- Your blood pressure and heart rate are stable (no signs of shock).
- You can breathe on your own and can safely use a nebulizer (a machine that turns medicine into a mist to breathe in).
- You are not on blood thinners (like warfarin or heparin) and do not have a bleeding disorder.
- You do not have severe kidney disease, a recent blood clot or stroke, and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving tranexamic acid, a medicine that helps blood clot, to stop bleeding in the lungs. One way is through a breathing mist (inhaled), and the other is through a vein (IV). The goal is to see which method works better and is safer for people who are coughing up blood.
This Phase 3 study tests whether inhaled tranexamic acid can reduce lung bleeding (pulmonary hemorrhage) in people with cancer who are on a breathing machine. If you qualify, you may receive the study drug to help stop bleeding in the lungs.
This study tests a procedure to stop bleeding in the lungs. It may help people who are coughing up blood that hasn't stopped with other treatments.
This trial tests whether a powder form of tranexamic acid can stop nosebleeds faster in people who come to the emergency room with active bleeding. It may offer a new option if standard treatments don't work well.
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
Hear when a new Pulmonary Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.